Imfinzi Continuously Demonstrates Survival Benefit in Limited Stage SCLC
New research shows Imfinzi significantly extends survival for patients with early-stage small cell lung cancer.Patients with limited-stage (cancer that is ...
Tag: durvalumab
Perioperative Imfinzi, Neoadjuvant Chemo Improves Survival in Muscle-Invasive Bladder Cancer
Patients with cisplatin-eligible muscle-invasive bladder cancer (MIBC) who received neoadjuvant (treatment as the first step to shrink a tumor) Imfinzi ...
Imfinzi After Primary Treatment Does Not Improve Disease-Free Survival in PD-L1-Positive NSCLC
Imfinzi was not shown to improve disease-free survival in patients with PD-L1-positive NSCLC.Disease-free survival (DFS; time after diagnosis during which ...
A New Era in Small Cell Lung Cancer Treatment
Dr. Debu Tripathy, editor-in-chief of CURE magazineAlthough advancements in treatments for small cell lung cancer (SCLC) are scarce for this ...
Treatment Breakthroughs Arrive for SCLC
Photography by Jill StifflerFor Sabrina Potts, the approval by the Food and Drug Administration (FDA) of Imdelltra (tarlatamab-dlle) in May ...